Goldman Sachs Group Inc Kamada LTD Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Kamada LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 75,146 shares of KMDA stock, worth $514,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,146
Previous 75,146
-0.0%
Holding current value
$514,750
Previous $496,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding KMDA
# of Institutions
39Shares Held
5.03MCall Options Held
14.3KPut Options Held
2K-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$11.3 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny808KShares$5.54 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA609KShares$4.17 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny448KShares$3.07 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3330KShares$2.26 Million0.19% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $307M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...